Pablo Avanzas
Prof Pablo Avanzas, MD, PhD, MSc, FESC is an expert in Cardiology at Central University Hospital of Asturias (Spain). As of November 2026, ScienceLeadR ranks Pablo Avanzas in the top 1% of experts worldwide for Myocardial Ischemia. Pablo Avanzas has authored 585 publications, the most recent in 2026, and is an investigator in 15 clinical trials, 2 of them ongoing. SLR score: 1,650 (community average: 125). How the SLR is computed.
LeadR Profile
Cardiology
Subspecialties: Public Health - Biostatistics - Surgery
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2004 - 2026Central University Hospital of Asturias - Interventional Cardiologist
2004 - 2026
Instituto de Investigación Sanitaria del Principado de Asturias - Investigador
2017 - 2026
University of Oviedo - Profesor Titular de Cardiología
2018 - 2026
University of Buenos Aires
2019 - 2026
Centro de Investigación en Red en Enfermedades Cardiovasculares
2023 - 2026
Centro de Investigación Biomédica en Red
2023 - 2026
Instituto de Salud Carlos III
2023 - 2026
Number : 585
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Influence of diabetes mellitus on dapagliflozin response after transcatheter aortic valve replacement (TAVR): insights from the DAPA-TAVI trial. PMID 43004293 — diabetes mellitus, mortality, aortic valve, transcatheter aortic valve replacement, therapeutics, diabetes complications | Cardiovasc Diabetol | 2026 | 0 |
| Mechanical Complications After Acute Myocardial Infarction: Contemporary Management, Treatment Selection, and Outcomes in a 10-Year Regional Referral Network. PMID 42941488 — mortality, myocardial infarction, income, aged, sex, aneurysm, false, therapeutics, rupture, ventricular septal rupture, mechanical circulatory support | J Clin Med | 2026 | 0 |
| Dapagliflozin After Transcatheter Aortic Valve Implantation According to Frailty in DapaTAVI Trial. PMID 42885795 — aortic valve stenosis, heart diseases, heart failure, aortic valve, transcatheter aortic valve replacement, frailty | J Am Heart Assoc | 2026 | 0 |
| Optical coherence tomography for the diagnosis and management of stent thrombosis. PMID 42745727 — stents, tomography, tomography, optical coherence, diagnosis, thrombosis, acute disease | REC Interv Cardiol | 2025 | 0 |
| Update on Perioperative Prevention of Cardiac Surgery-Associated Acute Kidney Injury. PMID 42739538 — acetylcysteine, kidney, cardiopulmonary bypass, reperfusion injury, renal replacement therapy, acute kidney injury | J Clin Med | 2026 | 0 |
Clinical Studies 15
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Cohort/Consortium Investigators 1
Ongoing Clinical Trials
2 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Surgical vs Transcatheter Aortic Valve Replacement in YOUNG Patients NCT06861361 — constriction, pathologic, aortic valve stenosis, bioprosthesis, heart, aged, aortic valve, transcatheter aortic valve replacement, surgical aortic valve replacement | N/A | Recruiting | 2025 |
| Early Transcatheter Mitral Valve Repair After Myocardial Infarction NCT06282042 — mitral valve, myocardial infarction, therapeutics, mitral valve insufficiency | N/A | Recruiting | 2024 |
LeadR Networks
Main global connection map